lipoxin a4 has been researched along with mezerein in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asadullah, K; Bauman, J; Colgan, SP; Fierro, IM; Giesen, C; Guilford, W; Parkinson, JF; Perez, HD; Schottelius, AJ | 1 |
Dong, L; Liu, B; Wu, HJ; Wu, SH | 1 |
2 other study(ies) available for lipoxin a4 and mezerein
Article | Year |
---|---|
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcimycin; Cell Movement; Chemotaxis, Leukocyte; Croton Oil; Disease Models, Animal; Diterpenes; Female; Guinea Pigs; Humans; Hydroxyeicosatetraenoic Acids; Hypersensitivity, Delayed; Iloprost; Inflammation; Leukotriene B4; Lipoxins; Mice; Phthalic Anhydrides; Skin; Terpenes | 2002 |
NF-kappaB is involved in inhibition of lipoxin A4 on dermal inflammation and hyperplasia induced by mezerein.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinogens; Cell Line; Cytokines; Dermis; Disease Models, Animal; Diterpenes; Female; Humans; Hyperplasia; Inflammation; Keratinocytes; Lipoxins; Mice; Mice, Inbred Strains; NF-kappa B | 2010 |